Skip to content
HowShorted

CNS Pharmaceuticals, Inc. short interest in 2022

In 2022, CNS Pharmaceuticals, Inc.'s disclosed short interest ran from 1.37% of shares outstanding on 15 Feb 2022 to 0.23% on 15 Nov 2022, a change of -1.14 percentage points. The year's high was 1.94% on 28 Feb 2022 and its low 0.19% on 31 Oct 2022, averaging 0.77% across 16 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 1.22 days on 30 Sep 2022. Full history: CNS Pharmaceuticals, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for CNS Pharmaceuticals, Inc. in 2022

2022 in figures

Start of year
1.37% (15 Feb 2022)
End of year
0.23% (15 Nov 2022)
Change
-1.14 pp
High
1.94% (28 Feb 2022)
Low
0.19% (31 Oct 2022)
Average
0.77%
Highest days to cover
1.22 (30 Sep 2022)
SEC filings marked
7

Every report in 2022

CNS Pharmaceuticals, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
15 Feb 20221.37%1.00
28 Feb 20221.94%1.00
15 Mar 20220.73%1.0010-K filed, results (8-K)
14 Apr 20221.01%1.00
29 Apr 20220.91%1.00
13 May 20220.73%1.0010-Q filed
31 May 20221.32%1.06results (8-K)
15 Jun 20220.71%1.00
30 Jun 20220.81%1.00
29 Jul 20220.40%1.00
15 Aug 20220.47%1.0010-Q filed, results (8-K)
31 Aug 20220.46%1.00
15 Sep 20220.53%1.00
30 Sep 20220.45%1.22
31 Oct 20220.19%1.00
15 Nov 20220.23%1.0010-Q filed

See also: CNS Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.